Welnox Enters into a Licensing Partnership with P&G for Vicks VapoRub

Welnox, a Martin Dow Group company, has entered into a licensing partnership with Procter & Gamble (P&G) for the distribution of Vicks VapoRub. Availability of the product is expected to commence in the upcoming weeks, as part of Welnox's strategy to broaden access to top-notch healthcare solutions for countless consumers nationwide.

Vicks VapoRub has long served as a trusted component in family care regimens, providing soothing relief during cough and cold symptoms. With over 125 years of history, Vicks holds a significant place in households, offering comfort against common cold symptoms such as nasal congestion, cough, headache, body ache, and discomfort related to breathing.

Anwar Zaman, CEO of Welnox, expressed his enthusiasm, stating that Vicks VapoRub is an iconic brand with enduring value, aligning perfectly with the company's vision to develop a robust, customer-focused healthcare portfolio. He believes there is considerable potential to leverage its strong foundation and unearth new avenues of growth in Pakistan.

Vicks VapoRub will soon be accessible in pharmacies nationwide in Pakistan, offering individuals a reliable option to mitigate their cold symptoms.